Safety and immunogenicity of AS03(B) adjuvanted split virion versus non-adjuvanted whole virion H1N1 influenza vaccine in UK children aged 6 months-12 years: open label, randomised, parallel group, multicentre study

Objectives To compare the safety, reactogenicity, and immunogenicity of an adjuvanted split virion H1N1 vaccine and a non-adjuvanted whole virion vaccine used in the pandemic immunisation programme in the United Kingdom. Design Open label, randomised, parallel group, phase II study. Setting Five UK...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Waddington, Claire S, Walker, W T, Oeser, C, Reiner, A, John, T, Wilkins, S, Casey, M, Eccleston, P E, Allen, R J, Okike, I, Ladhani, S, Sheasby, E, Hoschler, K, Andrews, N, Waight, P, Collinson, A C, Heath, P T, Finn, A, Faust, S N, Snape, M D, Miller, E, Pollard, A J
Médium: Artigo
Jazyk:Inglês
Vydáno: BMJ Publishing Group Ltd. 2010
Témata:
Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2877808/
https://ncbi.nlm.nih.gov/pubmed/20508026
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmj.c2649
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky